If you forgive me, Ms. Yeates, it seems that we're playing around the edges of the main issue here when we are talking about billions of dollars of potential savings and that we know how to get those savings, it would seem. Why do we continue to retain a barrier for Canadian citizens to get access to health care by retaining average pharmaceutical costs at 30% above industrial averages? All these programs I understand, but it's nibbling around the edges of a very large problem in access to health care for Canadians. Why don't we tackle the problem directly?
On November 20th, 2012. See this statement in context.